403406, Dec
An immediate precursor of NACA called diNACA has recently gained attention for cataract treatment
Broad Application in Cardiovascular Concerns: Major Potential In 2025, crucial research activities will be developing new applications of GLP-1 receptor agonists in heart conditions, including protective effects on the heart and blood vessels, probably decreasing the risk of heart attack, stroke, and other cardiovascular events
At Potere Health MD, youll never navigate your weight-loss journey alone
[13] These findings are further reinforced by pharmacovigilance data from the FDA Adverse Event Reporting System (FAERS) database (n=48,214 reports), where GLP-1RA-related gastrointestinal adverse events, including nausea (9651 vs 38,030) and vomiting (4383 vs 17,062), were lower with combination therapy compared to GLP-1RA monotherapy, suggesting improved tolerability when metformin is added
However, gastrointestinal symptoms like nausea and gastric discomfort are reported in 20-40% of patients, depending on dose and medication type